Outset Medical Inc (OM)
3.58
-0.25
(-6.53%)
USD |
NASDAQ |
Jul 08, 16:00
3.65
+0.07
(+1.96%)
After-Hours: 19:42
Outset Medical SG&A Expense (Annual): 141.46M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 141.46M |
December 31, 2022 | 130.00M |
December 31, 2021 | 101.39M |
Date | Value |
---|---|
December 31, 2020 | 75.58M |
December 31, 2019 | 29.18M |
December 31, 2018 | 17.53M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
29.18M
Minimum
2019
141.46M
Maximum
2023
95.52M
Average
101.39M
Median
2021
SG&A Expense (Annual) Benchmarks
AngioDynamics Inc | 144.25M |
Baxter International Inc | 3.896B |
Allurion Technologies Inc | 92.88M |
Perspective Therapeutics Inc | 21.06M |
Xtant Medical Holdings Inc | 64.29M |